Key regions: Australia, Europe, South Africa, United States, Netherlands
The Medical Cannabis market in Ireland has been steadily growing in recent years, reflecting a global trend towards the acceptance and legalization of medical cannabis for various health conditions.
Customer preferences: Patients in Ireland are increasingly turning to medical cannabis as an alternative form of treatment for a range of medical conditions. The shift in preferences towards natural and holistic remedies has driven demand for medical cannabis products in the country. Additionally, the growing awareness about the potential therapeutic benefits of cannabis has contributed to the changing preferences among consumers.
Trends in the market: One of the key trends in the Irish Medical Cannabis market is the expanding product offerings and availability of different forms of medical cannabis. Patients now have access to a variety of products such as oils, tinctures, capsules, and topical solutions, catering to different preferences and medical needs. Moreover, there is a growing trend towards personalized treatment plans involving medical cannabis, as healthcare providers and patients work together to find the most effective solutions.
Local special circumstances: Ireland's regulatory environment plays a significant role in shaping the Medical Cannabis market in the country. The gradual easing of restrictions and the introduction of specific regulations governing the use of medical cannabis have created a more conducive environment for patients to access these products. Additionally, the increasing number of clinics and healthcare professionals specializing in medical cannabis further facilitates the growth of the market.
Underlying macroeconomic factors: The economic landscape in Ireland, with a focus on healthcare innovation and research, has also contributed to the development of the Medical Cannabis market. The government's support for medical research and development, as well as initiatives to attract pharmaceutical companies, has created opportunities for the advancement of medical cannabis products and treatment options in the country. Furthermore, the changing attitudes towards cannabis at a global level have influenced the market dynamics in Ireland, leading to a more favorable outlook for the Medical Cannabis industry.
Data coverage:
Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.Modeling approach / Market size:
Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
